Company Filing History:
Years Active: 2008-2011
Title: Marion Gremse: Innovator in Modular Transfection Systems
Introduction
Marion Gremse is a notable inventor based in Kö'ln, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of modular transfection systems. With a total of 2 patents, her work focuses on innovative methods for gene therapy.
Latest Patents
Gremse's latest patents revolve around a method for transfection of cells using proteins capable of forming nucleoprotein filaments. The process involves modifying the protein with functional components that influence transfection steps. The nucleic acid to be transfected is loaded with the modified protein, forming a filament-like complex that is then introduced to the target cells. This invention also includes a transfection agent consisting of nucleoprotein filaments, which can be used to produce drugs for gene therapeutic treatments in humans and animals. Additionally, her patents cover pharmaceutical preparations for gene therapy and the use of transfection agents in kits.
Career Highlights
Throughout her career, Marion Gremse has worked with prominent companies in the biotechnology sector, including Lonza Cologne GmbH and Amaxa AG. Her experience in these organizations has contributed to her expertise in the field of transfection systems and gene therapy.
Collaborations
Some of her notable coworkers include Hanns-Martin Schmidt and Ludger Altrogge. Their collaboration has likely enhanced the development and application of her innovative technologies.
Conclusion
Marion Gremse's contributions to modular transfection systems represent a significant advancement in gene therapy. Her innovative methods and collaborative efforts continue to influence the biotechnology landscape.